Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Genetic Testing for Malformations of Cortical Development: A Clinical Diagnostic Study

B. Straka, B. Hermanovska, L. Krskova, J. Zamecnik, M. Vlckova, M. Balascakova, P. Tesner, P. Jezdik, M. Tichy, M. Kyncl, A. Musilova, P. Lassuthova, P. Marusic, P. Krsek

. 2022 ; 8 (5) : e200032. [pub] 20220927

Status neindexováno Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22031630

BACKGROUND AND OBJECTIVES: Malformations of cortical development (MCD), though individually rare, constitute a significant burden of disease. The diagnostic yield of next-generation sequencing (NGS) in these patients varies across studies and methods, and novel genes and variants continue to emerge. METHODS: Patients (n = 123) with a definite radiologic or histopathologic diagnosis of MCD, with or without epilepsy were included in this study. They underwent NGS-based targeted gene panel (TGP) testing, whole-exome sequencing (WES), or WES-based virtual panel testing. Selected patients who underwent epilepsy surgery (n = 69) also had somatic gene testing of brain tissue-derived DNA. We analyzed predictors of positive germline genetic finding and diagnostic yield of respective methods. RESULTS: Pathogenic or likely pathogenic germline genetic variants were detected in 21% of patients (26/123). In the surgical subgroup (69/123), we performed somatic sequencing in 40% of cases (28/69) and detected causal variants in 18% (5/28). Diagnostic yield did not differ between TGP, WES-based virtual gene panel, and open WES (p = 0.69). Diagnosis of focal cortical dysplasia type 2A, epilepsy, and intellectual disability were associated with positive results of germline testing. We report previously unpublished variants in 16/26 patients and 4 cases of MCD with likely pathogenic variants in non-MCD genes. DISCUSSION: In this study, we are reporting genetic findings of a large cohort of MCD patients with epilepsy or potentially epileptogenic MCD. We determine predictors of successful ascertainment of a genetic diagnosis in real-life setting and report novel, likely pathogenic variants in MCD and non-MCD genes alike.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22031630
003      
CZ-PrNML
005      
20240716080604.0
007      
ta
008      
230119s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1212/NXG.0000000000200032 $2 doi
035    __
$a (PubMed)36324633
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Straka, Barbora $u Department of Paediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital $1 https://orcid.org/0000000184482833 $7 xx0319616
245    10
$a Genetic Testing for Malformations of Cortical Development: A Clinical Diagnostic Study / $c B. Straka, B. Hermanovska, L. Krskova, J. Zamecnik, M. Vlckova, M. Balascakova, P. Tesner, P. Jezdik, M. Tichy, M. Kyncl, A. Musilova, P. Lassuthova, P. Marusic, P. Krsek
520    9_
$a BACKGROUND AND OBJECTIVES: Malformations of cortical development (MCD), though individually rare, constitute a significant burden of disease. The diagnostic yield of next-generation sequencing (NGS) in these patients varies across studies and methods, and novel genes and variants continue to emerge. METHODS: Patients (n = 123) with a definite radiologic or histopathologic diagnosis of MCD, with or without epilepsy were included in this study. They underwent NGS-based targeted gene panel (TGP) testing, whole-exome sequencing (WES), or WES-based virtual panel testing. Selected patients who underwent epilepsy surgery (n = 69) also had somatic gene testing of brain tissue-derived DNA. We analyzed predictors of positive germline genetic finding and diagnostic yield of respective methods. RESULTS: Pathogenic or likely pathogenic germline genetic variants were detected in 21% of patients (26/123). In the surgical subgroup (69/123), we performed somatic sequencing in 40% of cases (28/69) and detected causal variants in 18% (5/28). Diagnostic yield did not differ between TGP, WES-based virtual gene panel, and open WES (p = 0.69). Diagnosis of focal cortical dysplasia type 2A, epilepsy, and intellectual disability were associated with positive results of germline testing. We report previously unpublished variants in 16/26 patients and 4 cases of MCD with likely pathogenic variants in non-MCD genes. DISCUSSION: In this study, we are reporting genetic findings of a large cohort of MCD patients with epilepsy or potentially epileptogenic MCD. We determine predictors of successful ascertainment of a genetic diagnosis in real-life setting and report novel, likely pathogenic variants in MCD and non-MCD genes alike.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hermanovska, Barbora $u Department of Paediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital
700    1_
$a Krskova, Lenka $u Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital
700    1_
$a Zamecnik, Josef $u Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital
700    1_
$a Vlckova, Marketa $u Department of Biology and Medical Genetics, Second Faculty of Medicine, Charles University and Motol University Hospital
700    1_
$a Balascakova, Miroslava $u Department of Biology and Medical Genetics, Second Faculty of Medicine, Charles University and Motol University Hospital
700    1_
$a Tesner, Pavel $u Department of Biology and Medical Genetics, Second Faculty of Medicine, Charles University and Motol University Hospital
700    1_
$a Jezdik, Petr $u Faculty of Electrical Engineering, Department of Circuit Theory, Czech Technical University in Prague
700    1_
$a Tichy, Michal $u Department of Neurosurgery, Second Faculty of Medicine, Charles University and Motol University Hospital
700    1_
$a Kyncl, Martin $u Department of Radiology, Second Faculty of Medicine, Charles University and Motol University Hospital
700    1_
$a Musilova, Alena $u Department of Paediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital
700    1_
$a Lassuthova, Petra $u Department of Paediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital
700    1_
$a Marusic, Petr $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Czech Republic
700    1_
$a Krsek, Pavel $u Department of Paediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital $1 https://orcid.org/0000000230711589
773    0_
$w MED00200175 $t Neurology. Genetics $x 2376-7839 $g Roč. 8, č. 5 (2022), s. e200032
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36324633 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230119 $b ABA008
991    __
$a 20240716080601 $b ABA008
999    __
$a ok $b bmc $g 1889577 $s 1182963
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2022 $b 8 $c 5 $d e200032 $e 20220927 $i 2376-7839 $m Neurology. Genetics $n Neurol Genet $x MED00200175
LZP    __
$a Pubmed-20230119

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace